Print Page

被 發 現 含 有 未 標 示 西 藥 的 產 品

Australia: Safety advisory: Chapter Plus+ By Backslim Capsules contain the undeclared substance sibutramine (Chinese Only)
The Therapeutic Goods Administration (TGA) has tested a product labelled Chapter Plus+ By Backslim Capsules and found that the capsules contain the undeclared substance sibutramine. Consumers are advised that sibutramine is a prescription-only medicine (which was the active ingredient in Reductil). It was withdrawn in Oct 2010 after a study showed an increased risk of major cardiac events. TGA investigations have shown that a number of people in Australia may have bought the product online.

Consumers are advised to stop taking the product and take any remaining capsules to their local pharmacy for safe disposal. If they have any concerns arising from their use of this product, consult their health care practitioner.

Please refer to the following website in TGA for details:

In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by Singapore Health Sciences Authority, and was posted on the Drug Office website on 21 Jul 2018.

Ends/Thursday, Nov 1, 2018
Issued at HKT 15:00
Related Information:
Australia: Safety advisory: Li Da Weight Loss Capsules contain the undeclared su... 上載於 2018-11-01
新加坡:衞生科學局警示:兩種網上銷售的減肥產品'Li Da'及'Chapter Plus'被發現含有禁用成分西布曲明 上載於 2018-07-21